Decitabine improves response rate and prolongs progression-free survival in older patients with newly diagnosed acute myeloid leukemia and with monosomal karyotype: A subgroup analysis of the DACO-016 trial.

Agnieszka ŚwiątekEwa WawrzyniakAgnieszka PlutaTadeusz RobakGrzegorz J MazurAnna DmoszynskaJaroslav CermakAlbert OriolDaniel LysakChris ArthurMargaret DoyleLiang XiuFarhad RavandiHagop M Kantarjian

Published in: American journal of hematology (2018)

Keyphrases

acute myeloid leukemia
free survival
newly diagnosed
phase iii
allogeneic hematopoietic stem cell transplantation
study protocol
clinical trial
community dwelling
phase ii
physical activity
middle aged
open label
randomized controlled trial
acute lymphoblastic leukemia